C4 Therapeutics Inc. (CCCC) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

C4 Therapeutics Inc.

NASDAQ: CCCC · Real-Time Price · USD
2.27
0.06 (2.71%)
At close: Oct 03, 2025, 3:59 PM
2.27
0.00%
After-hours: Oct 03, 2025, 07:37 PM EDT

C4 Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-26.02M -26.32M -34.57M -24.67M -17.72M -28.36M -34.75M -27.04M -35.92M -34.78M -37.19M -31.96M -27.41M -31.62M -15.66M -24.68M -22.58M -20.97M
Depreciation & Amortization
615K 456K 480K -2.73M 448K 448K 1.69M 447K 458K 545K 521K 415K 435K 305K 323K 330K 388K 451K
Stock-Based Compensation
4.99M 5.51M 8.23M 8.83M 6.38M 6.21M 6.36M 8.2M 6.42M 6.25M 6.92M 6.01M 8.15M 8.94M 6.35M 6.09M 5.23M 3.85M
Other Working Capital
-114K -8.25M 360K -641K -5.85M 4.97M 14.53M -10.57M 7.84M -7.03M 401K -2.74M -6.32M -9.04M -15.06M -3.65M -2.57M -3.77M
Other Non-Cash Items
1.11M 892K 503K 3.66M 45K 223K 20.16M 1.65M 1.75M 1.08M 1.28M 1.72M 2.3M 2.02M 614K 513K 505K 502K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -20.87M -472K -1.08M n/a n/a n/a n/a n/a 847K 558K 372K 102K
Change in Working Capital
7.25M -13.82M 7.42M -9.22M 5.87M 3.36M 3.4M -13.5M 9.38M -6.22M -660K -4.21M -5.67M -6.24M -18.15M -1.16M -1.92M -8.86M
Operating Cash Flow
-12.06M -33.28M -17.93M -24.13M -4.97M -18.12M -24.01M -30.71M -19M -33.13M -29.13M -28.02M -22.2M -26.6M -25.67M -18.36M -18M -24.93M
Capital Expenditures
-185K n/a 4K 13K -197K n/a -157K -600K -362K -589K -1.49M -3.31M -529K -172K -109K n/a -747K -421K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -32.1M -58.33M -15.51M -54.12M -10.77M -23.22M -33.76M n/a n/a n/a n/a n/a
Purchase of Investments
-21.68M -25.64M -40.78M -68.56M -67.22M -107.75M -37.88M -31.94M -48.64M -11.44M -56.29M -55.11M -31.91M -76.22M -145.42M -154.7M -61.32M -176.3M
Sales Maturities Of Investments
60.79M 54.77M 54.45M 68.71M 55.72M 54.35M 69.98M 90.27M 64.15M 65.56M 67.06M 78.33M 65.67M 72.39M 86.11M 54.08M 94.5M 114.99M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 32.1M 58.33M 15.51M 54.12M 10.77M 23.22M 33.76M -3.83M -59.3M -100.63M 33.18M -61.31M
Investing Cash Flow
38.92M 29.13M 13.67M 162K -11.71M -53.4M 31.95M 57.73M 15.15M 53.53M 9.28M 19.91M 33.23M -4M -59.41M -100.63M 32.43M -61.73M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a -11M -750K -750K n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a -155K n/a -85K n/a -109K n/a -16K n/a -94K n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 109K 1K 310K n/a 603K -1K 263K 4K 104K 47K 361K 259K 480K 466K 1.05M 170.5M -151K
Financial Cash Flow
n/a -46K 112K 10.51M 135K 34.58M 57.67M -10.75M -746K -684K 47K 361K 259K 480K 466K 584K 170.5M -151K
Net Cash Flow
26.86M -4.21M -4.15M -13.46M -16.55M -36.93M 65.62M 16.27M -4.59M 19.72M -19.8M -7.75M 11.29M -30.12M -84.62M -118.4M 184.93M -86.81M
Free Cash Flow
-12.24M -33.28M -17.93M -24.12M -5.17M -18.12M -24.17M -31.31M -19.36M -33.71M -30.62M -31.32M -22.72M -26.77M -25.78M -18.36M -18.75M -25.36M